Suppliers / EUROAPI Germany

EUROAPI Germany

Germany Updated 9 July 2026

EUROAPI Germany is an API manufacturer based in Germany. It holds 6 active US drug master files across a filed portfolio of 6 molecules. Its most recent recorded inspection, by US FDA, closed on 4 March 2022 as VAI.

6
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 4 March 2022 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Germany, Germany 3020754015

What they file, and where

Molecule Regulators Docs
Clobazam US FDA 1
Furosemide US FDA 1
Glimepiride US FDA 1
Ketoprofen US FDA 1
Leflunomide US FDA 1
Ramipril US FDA 1

Also appears on these molecule pages

Comparing suppliers?

Choose your molecules and target markets. EUROAPI Germany comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 4 March 2022.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability